Moreover, the tumour‐suppressive role of METTL14 in p53‐wild‐type CRC cells, while not significantly affecting p53‐mutant or p53‐null CRC cells, highlights the influence of tumour heterogeneity on m6A regulators' roles.72 This evidence concerns the gene TP53 and neoplasm.